...
首页> 外文期刊>British Journal of Pharmacology >Bioactive β-bend structures for the antagonist hα CGRP_(8-37) at the CGRP_1 receptor of the rat pulmonary artery
【24h】

Bioactive β-bend structures for the antagonist hα CGRP_(8-37) at the CGRP_1 receptor of the rat pulmonary artery

机译:拮抗剂hαCGRP_(8-37)在大鼠肺动脉CGRP_1受体上的生物活性β弯曲结构

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

1. The aim of this study was to determine β-bend structures and the role of the N- and C-terminus in the antagonist hα CGRP_(8-37) at the rat pulmonary artery CGRP receptor mediating hα CGRP relaxation. 2. Hα CGRP_(8-37) Pro~(16) (10~(-6) M), with a bend-biasing residue (proline) at position 16, did not antagonize hα CGRP responses, while a structure-conserving amino acid (alanine~(16)) at the same position retained antagonist activity (apparent pK_B 6.6 ± 0.1; 10~(-6) M). Hα CGRP_(8-37) Pro~(19) (10~(-6) M), with proline at position 19 was an antagonist (apparent pK_B 6.9 ± 0.1). 3. Incorporation of a β-bend forcing residue, BTD (beta-turn dipeptide), at positions 19 and 20 in hα CGRP_(8-37) (10~(-6) M) antagonized hα CGRP responses (apparent pK_B 7.2 ± 0.2); and BTD at positions 19,20 and 33,34 within hα CGRP_(8-37) was a competitive antagonist (pA_2 7.2; Schild plot slope 1.0 ± 0.1). 4. Hα CGRP_(8-37) analogues, substituted at the N-terminus by either glycine~8 or des-NH_2 valine~8 or proline~8 were all antagonists (apparent pK_B 6.9 ± 0.1; (10~(-6) M), 7.0 ± 0.1 (10~(-6) M), and pA_2 7.0 (slope 1.0 ± 0.2), respectively); while replacements by proline~8 together with glutamic acid~(10,14) in hα CGRP_(8-37) (10~(-6)M) or alanine amide~(37) at the C-terminus of hα CGRP_(8-37) (10~(-5) M) were both inactive compounds. 5. In conclusion, possible bioactive structures of hα CGRP_(8-37) include two β-bends (at 18-21 and 32-35), which were mimicked by BTD incorporation. Within hα CGRP_(8-37), the N-terminus is not essential for antagonism while the C-terminus may interact directly with CGRP_1 receptors in the rat pulmonary artery.
机译:1.这项研究的目的是确定介导hαCGRP松弛的大鼠肺动脉CGRP受体中β弯曲结构以及N和C末端在拮抗剂hαCGRP_(8-37)中的作用。 2.HαCGRP_(8-37)Pro〜(16)(10〜(-6)M),在16位具有弯曲偏向残基(脯氨酸),没有拮抗hαCGRP反应,而结构保守的氨基在相同位置的酸(丙氨酸〜(16))保留拮抗剂活性(表观pK_B 6.6±0.1; 10〜(-6)M)。脯氨酸在19位的HαCGRP_(8-37)Pro〜(19)(10〜(-6)M)是拮抗剂(表观pK_B 6.9±0.1)。 3.在hαCGRP_(8-37)(10〜(-6)M)拮抗的hαCGRP反应中,β-弯曲强迫残基BTD(β-转二肽)的掺入(表观pK_B 7.2± 0.2); hCGRP_(8-37)中19,20和33.34位的BTD是竞争性拮抗剂(pA_2 7.2; Schild图斜率1.0±0.1)。 4.在N端被甘氨酸〜8或des-NH_2缬氨酸〜8或脯氨酸〜8取代的HαCGRP_(8-37)类似物都是拮抗剂(表观pK_B 6.9±0.1;(10〜(-6) M),7.0±0.1(10〜(-6)M)和pA_2 7.0(斜率1.0±0.2));而在hαCGRP_(8的C端)中被脯氨酸〜8连同谷氨酸〜(10,14)置换在hαCGRP_(8-37)(10〜(-6)M)或丙氨酸酰胺〜(37)中-37)(10〜(-5)M)均为非活性化合物。 5.总之,hαCGRP_(8-37)可能的生物活性结构包括两个β弯曲(分别在18-21和32-35处),这些弯曲可以通过BTD掺入来模拟。在hαCGRP_(8-37)中,N末端不是拮抗作用所必需的,而C末端可能与大鼠肺动脉中的CGRP_1受体直接相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号